Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Loperamide hydrochloride 2 mg Tablet Apotex Inc., Weston, Ontario, Canada Apo-Loperamide Bifonazole 1% w/w Cream, topical Bayer AG., Leverkusen, Germany and Bayer Australia Limited, Health Care Operations Centre, Mulgrave, Victoria, Australia Canesten Once Daily Bifonazole Desonide 0.05% w/w Ointment, topical Laboratoires Galderma, Zone d'activite de Montdesir, Alby Sur Cheran, France Desowen Desonide 0.05% w/w Cream, topical Laboratoires Galderma, Zone d'activite de Montdesir, Alby Sur Cheran, France Desowen Desonide 0.05% w/w Lotion, skin Laboratoires Galderma, Zone d'activite de Montdesir, Alby Sur Cheran, France Desowen Salicylic acid 27% w/w Gel, topical Stiefel Laboratories (Ireland) Limited, Sligo, Ireland Duofilm Codeine phosphate (anhydrous) 12.8 mg, ibuprofen 200 mg Tablet The Boots Company Plc., Beeston, Nottingham, United Kingdom Nurofen Plus Camphor 1.24% w/w, menthol 5.71% w/w, methyl salicylate 6.29% w/w Transdermal patch Hisamitsu Pharmaceutical Co Inc., Tosu, Saga, Japan Salonpas Betahistine hydrochloride 4 mg, 8 mg, 16 mg Tablets Solvay Duphar BV., Olst, The Netherlands Serc Carmellose sodium 2.5 mg/mL Drops, eye, solution Ciba Vision Sterile Manufacturing, Mississauga, Ontario, Canada Thera Tears Dated this 11th day of January 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.